Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001410578-14-000144
Filing Date
2014-04-22
Accepted
2014-04-22 13:14:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 138294
2 g43003bg03i001.jpg GRAPHIC 1357
3 g43003bg01i001.jpg GRAPHIC 1801
4 g43003bg01i002.jpg GRAPHIC 1357
  Complete submission text file 0001410578-14-000144.txt   145779
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations